Report cover image

Global Viral Sample Preservation Solution Supply, Demand and Key Producers, 2026-2032

Publisher GlobalInfoResearch
Published Jan 27, 2026
Length 169 Pages
SKU # GFSH20885037

Description

The global Viral Sample Preservation Solution market size is expected to reach $ 298 million by 2032, rising at a market growth of 4.8% CAGR during the forecast period (2026-2032).

Viral Sample Preservation Solution is an integrated technical system combining specialized preservatives, sterile containers, and standardized operating procedures, designed to maintain the integrity of viral particles (viability) or nucleic acids (RNA/DNA) during collection, transport, and storage. It includes inactivated and non-inactivated types, adapts to different temperature conditions (ambient, low-temperature, ultra-low-temperature), and prevents sample degradation or contamination, providing reliable sample support for viral detection, scientific research, and vaccine development.

In 2025, global Viral Sample Preservation Solution production reached approximately 52 million units, with an average global market price of around US$ 4 per unit.

The Viral Sample Preservation Solution market is experiencing significant growth driven by several key factors: Market Drivers: Rising burden of infectious diseases: Increasing prevalence of various viral diseases, including COVID-19, influenza, and emerging viral threats, fuels demand for efficient sample preservation for diagnostics and research. Expanding laboratory testing and research activities: Growing focus on public health surveillance, vaccine development, and antiviral research necessitates reliable viral sample preservation. Focus on biosafety and sample integrity: Concerns about sample degradation and potential loss of viral RNA/DNA during transport and storage drive demand for high-quality preservation solutions. Technological advancements: Development of novel stabilization technologies, inactivation methods, and combination solutions with enhanced efficacy and broader viral compatibility. Increasing awareness and adoption in various settings: Healthcare facilities, research laboratories, and even field workers are recognizing the benefits of using preservation solutions for improved sample handling and testing accuracy. Market Challenges: Regulation and compliance: Stringent regulations governing viral sample handling and transportation require manufacturers to ensure solution compliance and safety. Competition and price sensitivity: Wide range of available solutions creates price competition, influencing purchasing decisions. Developing markets: Limited healthcare infrastructure and awareness in some regions pose challenges for market penetration. Overall, the Viral Sample Preservation Solution market presents promising opportunities for manufacturers, distributors, and research institutions. Focusing on addressing regulatory challenges, developing novel solutions, and providing cost-effective options will be crucial to ensuring the market's sustainable growth and contribution to global health initiatives.

This report studies the global Viral Sample Preservation Solution production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Viral Sample Preservation Solution and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Viral Sample Preservation Solution that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Viral Sample Preservation Solution total production and demand, 2021-2032, (M Units)

Global Viral Sample Preservation Solution total production value, 2021-2032, (USD Million)

Global Viral Sample Preservation Solution production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Units), (based on production site)

Global Viral Sample Preservation Solution consumption by region & country, CAGR, 2021-2032 & (M Units)

U.S. VS China: Viral Sample Preservation Solution domestic production, consumption, key domestic manufacturers and share

Global Viral Sample Preservation Solution production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Units)

Global Viral Sample Preservation Solution production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Units)

Global Viral Sample Preservation Solution production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Units)

This report profiles key players in the global Viral Sample Preservation Solution market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Longhorn Vaccines and Diagnostics, EKF Diagnostics Holdings, Biosigma, BIOBASE, BD, Aptaca, Orient Gene, Mole Bioscience, Biocomma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Viral Sample Preservation Solution market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Viral Sample Preservation Solution Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Viral Sample Preservation Solution Market, Segmentation by Type:
Inactivated
Non-inactivated

Global Viral Sample Preservation Solution Market, Segmentation by Preservation Temperature Requirement:
Ambient Temperature Preservation Solution
Low-Temperature Preservation Solution
Ultra-Low Temperature Preservation Solution

Global Viral Sample Preservation Solution Market, Segmentation by Target Sample Type:
Swab Sample Preservation Solution
Tissue Sample Preservation Solution
Others

Global Viral Sample Preservation Solution Market, Segmentation by Application:
Hospital
Clinic
Others

Companies Profiled:
Thermo Fisher Scientific
Longhorn Vaccines and Diagnostics
EKF Diagnostics Holdings
Biosigma
BIOBASE
BD
Aptaca
Orient Gene
Mole Bioscience
Biocomma
Beijing Hanbaihan Medical
Darui Biotech
Hangzhou LifeReal Biotechnology
Copan Diagnostics
BioServUK
Guangdong Hybribio Biotech
Haimen Shengbang Laboratory Equipment
Longsee Biomedical
Hangzhou Jiuyang Biotechnology
Jifan Biotechnology (Beijing)
Puritan Medical Products
Cardinal Health
Medline Industries
Shandong Chengwu Medical Products Factory

Key Questions Answered:

1. How big is the global Viral Sample Preservation Solution market?

2. What is the demand of the global Viral Sample Preservation Solution market?

3. What is the year over year growth of the global Viral Sample Preservation Solution market?

4. What is the production and production value of the global Viral Sample Preservation Solution market?

5. Who are the key producers in the global Viral Sample Preservation Solution market?

6. What are the growth factors driving the market demand?

Table of Contents

169 Pages
1 Supply Summary
2 Demand Summary
3 World Manufacturers Competitive Analysis
4 United States VS China VS Rest of the World
5 Market Analysis by Type
6 Market Analysis by Preservation Temperature Requirement
7 Market Analysis by Target Sample Type
8 Market Analysis by Application
9 Company Profiles
10 Industry Chain Analysis
11 Research Findings and Conclusion
12 Appendix
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.